JAVYGTOR (SAPROPTERIN DIHYDROCHLORIDE)
JAVYGTOR (SAPROPTERIN DIHYDROCHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: JAVYGTOR; Generic name: SAPROPTERIN DIHYDROCHLORIDE; Manufacturer: Dr. Reddys Laboratories Inc.
| Brand name | JAVYGTOR |
|---|---|
| Generic name | SAPROPTERIN DIHYDROCHLORIDE |
| Manufacturer | Dr. Reddys Laboratories Inc |
| Used for | 1 INDICATIONS AND USAGE JAVYGTOR (sapropterin dihydrochloride) is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin-(BH4-) responsive Phenylketonuria (PKU). JAVYGTOR is to be used in conjunction with a Phe-restricted diet. JAVYGTOR (sapropterin dihydrochloride) is a phenylalanine hydroxylase activator indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). JAVYGTOR is to be used in conjunction with a Phe-restricted d |
| Dosage | 2 DOSAGE AND ADMINISTRATION All patients with PKU who are being treated with JAVYGTOR (sapropterin dihydrochloride) should also be treated with a Phe-restricted diet, including dietary protein and Phe restriction. ( 2.1 ) Starting Dosage Pediatric patients 1 month to 6 years: The recommended starting dose of JAVYGTOR is 10 mg/kg administered orally once daily. (2.2) Patients 7 years and older: The recommended starting dose of JAVYGTOR is 10 to 20 mg/kg administered orally once daily. (2.2) Dosa |
| Active ingredient(s) | SAPROPTERIN DIHYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1590afa1-baa4-70e5-5a3b-468401c71044 |